Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-039836

Options or other derivatives

  • Director acquired 18,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Svoronos Dawn · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-28 Grant or award : show line 1 in the form Stock Option (Right to Buy) +18,000 18,000 D
Loading xslF345X03/doc4.xml…